| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 3 Aug 2026 | 21 Jul 2026 |
| Glaxosmithkline Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/08/2026 ,inter alia, to consider and approve approve and take on record the Un-audited financial results for the first quarter ended 30th June 2026. Outcome of Meeting (As per BSE Announcement dated on: 03.07.2026) | ||
| Board Meeting | 13 May 2026 | 22 Apr 2026 |
| Glaxosmithkline Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2026 inter alia to consider and approve Audited Financial Results (Standalone & Consolidated) for the year ended 31st March 2026 and dividend if any Outcome of Meeting (As per BSE Announcement dated on: 13.05.2026) | ||
| Board Meeting | 2 Mar 2026 | 2 Mar 2026 |
| Outcome Of Board Meeting | ||
| Board Meeting | 9 Feb 2026 | 6 Jan 2026 |
| Glaxosmithkline Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 inter alia to consider and approve take on record the Un-audited financial results for the third quarter & nine months ended 31st December 2025. Outcome of Meeting (As Per BSE Announcement Dated on: 09/02/2026) | ||
| Board Meeting | 6 Nov 2025 | 27 Oct 2025 |
| Glaxosmithkline Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2025 ,inter alia, to consider and approve Approval of Un-audited financial results for the quarter & half year ended 30th September 2025. Outcome of meeting (As Per Bse Announcement dated on 06/11/2025) | ||
At around 2.14 PM, GSK Pharma was trading 0.28% higher at ₹2,806.70 per piece, against the previous close of ₹2,798.80 on NSE.
Here are some of the stocks that may see significant price movement today: GIC Re, GSK Pharma, Godfrey Philips, etc.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
